Gestala confirms $21.6M raise, $58M+ in commitments, $100-200M valuation — TechCrunch verified
Summary
TechCrunch confirmed Gestala raised $21.6M (¥150M) two months after launch at a $100-200M valuation per Phoenix Peng, with $58M+ in total commitments making it 2.7x oversubscribed. Co-led by Guosheng Capital and Dalton Venture, with Tsing Song Capital, Gobi Ventures, Fourier Intelligence, Liepin, and Seas Capital. Gestala develops non-invasive ultrasound-based BCIs targeting chronic pain, depression, Alzheimer's, Parkinson's, stroke rehabilitation, and epilepsy.
Why it matters
TechCrunch confirmation of the 2.7x oversubscription resolves any questions about the quality of Gestala's investor base — the $58M in commitments that were turned away represent real institutional demand, not a capacity constraint. The $100-200M valuation two months after founding reflects Phoenix Peng's serial entrepreneur premium and the extraordinary investor demand for non-invasive Chinese BCI technology.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial